Poland - Nowy Sącz: Antineoplastic and immunomodulating agents

Release

ID
ocds-pyfy63:2020-543335:2020-543335
Date
2020-11-13
Language
PL
Tags
tender

Release in JSON

Process

ID (OCID)
ocds-pyfy63:2020-543335

Releases in JSON

Tender

Title
Poland - Nowy Sącz: Antineoplastic and immunomodulating agents
Award criteria
ratedCriteria
Award criteria details
The most economic tender
Award period
2020-12-15 - ?
Eligibility criteria
Suitability:

Warunek ten zostanie spełniony, jeżeli Wykonawca wykaże, że posiada dokumenty potwierdzające posiadanie uprawnień do wykonywania określonej działalności lub czynności tj. koncesję, zezwolenie, lub licencje na prowadzenie hurtowni farmaceutycznej w zakresie obrotu produktami leczniczymi lub w przypadku Wykonawcy prowadzącego skład konsygnacyjny – zezwolenie na jego prowadzenie.
Main procurement category
goods
Procurement method
open
Procurement method details
Open procedure
Tender period
2020-11-13 - 2020-12-15
Value
18 199 035.81 PLN
Minimum value
18 199 035.81 PLN

Tender item

ID
ocds-pyfy63:2020-543335:obj:1
Classification
CPV / 33652000
Description
Leki przeciwnowotworowe.

Tender item

ID
ocds-pyfy63:2020-543335:obj:2
Classification
CPV / 33652000
Description
Calcii folinas.

Tender item

ID
ocds-pyfy63:2020-543335:obj:3
Classification
CPV / 33652000
Description
Filgasterim.

Tender item

ID
ocds-pyfy63:2020-543335:obj:4
Classification
CPV / 33652000
Description
Irinotecan.

Tender item

ID
ocds-pyfy63:2020-543335:obj:5
Classification
CPV / 33652000
Description
Bendamustine.

Tender item

ID
ocds-pyfy63:2020-543335:obj:6
Classification
CPV / 33652000
Description
Capecytabina.

Tender item

ID
ocds-pyfy63:2020-543335:obj:7
Classification
CPV / 33652000
Description
Gefitinibum.

Tender item

ID
ocds-pyfy63:2020-543335:obj:8
Classification
CPV / 33652000
Description
Oxaliplatin.

Tender item

ID
ocds-pyfy63:2020-543335:obj:9
Classification
CPV / 33652000
Description
BCG Vaccinum.

Tender item

ID
ocds-pyfy63:2020-543335:obj:10
Classification
CPV / 33652000
Description
Ac.levofolicum.

Tender item

ID
ocds-pyfy63:2020-543335:obj:11
Classification
CPV / 33652000
Description
Darbopoetyna alfa.

Tender item

ID
ocds-pyfy63:2020-543335:obj:12
Classification
CPV / 33652000
Description
Bevacizumab.

Tender item

ID
ocds-pyfy63:2020-543335:obj:13
Classification
CPV / 33652000
Description
Erlotinib.

Tender item

ID
ocds-pyfy63:2020-543335:obj:14
Classification
CPV / 33652000
Description
Rituximab.

Tender item

ID
ocds-pyfy63:2020-543335:obj:15
Classification
CPV / 33652000
Description
Obinutuzumab.

Tender item

ID
ocds-pyfy63:2020-543335:obj:16
Classification
CPV / 33652000
Description
Peruzumab.

Tender item

ID
ocds-pyfy63:2020-543335:obj:17
Classification
CPV / 33652000
Description
Trastuzumab.

Tender item

ID
ocds-pyfy63:2020-543335:obj:18
Classification
CPV / 33652000
Description
Olaparyb.

Tender item

ID
ocds-pyfy63:2020-543335:obj:19
Classification
CPV / 33652000
Description
Doxorubicinum lizosomalna pegylatum.

Tender item

ID
ocds-pyfy63:2020-543335:obj:20
Classification
CPV / 33652000
Description
Vinorelbinum.

Tender item

ID
ocds-pyfy63:2020-543335:obj:21
Classification
CPV / 33652000
Description
Bortezomib.

Tender item

ID
ocds-pyfy63:2020-543335:obj:22
Classification
CPV / 33652000
Description
Anagrelid.

Tender item

ID
ocds-pyfy63:2020-543335:obj:23
Classification
CPV / 33652000
Description
Lapatinib.

Tender item

ID
ocds-pyfy63:2020-543335:obj:24
Classification
CPV / 33652000
Description
Cytarabina liposomalna.

Tender item

ID
ocds-pyfy63:2020-543335:obj:25
Classification
CPV / 33652000
Description
Azacytydyna.

Tender item

ID
ocds-pyfy63:2020-543335:obj:26
Classification
CPV / 33652000
Description
Octan abirateronu.

Tender item

ID
ocds-pyfy63:2020-543335:obj:27
Classification
CPV / 33652000
Description
Certyzynib.

Tender item

ID
ocds-pyfy63:2020-543335:obj:28
Classification
CPV / 33652000
Description
Imatinib.

Tender item

ID
ocds-pyfy63:2020-543335:obj:29
Classification
CPV / 33652000
Description
Afatynib.

Tender item

ID
ocds-pyfy63:2020-543335:obj:30
Classification
CPV / 33652000
Description
Enzalutamid.

Tender item

ID
ocds-pyfy63:2020-543335:obj:31
Classification
CPV / 33652000
Description
Ozymertynib.

Tender item

ID
ocds-pyfy63:2020-543335:obj:32
Classification
CPV / 33652000
Description
Ruksolitynib.

Tender item

ID
ocds-pyfy63:2020-543335:obj:33
Classification
CPV / 33652000
Description
Ibrutynib.

Tender item

ID
ocds-pyfy63:2020-543335:obj:34
Classification
CPV / 33652000
Description
Eltrombopag.

Tender item

ID
ocds-pyfy63:2020-543335:obj:35
Classification
CPV / 33652000
Description
Piksantron dimaleas.

Tender item

ID
ocds-pyfy63:2020-543335:obj:36
Classification
CPV / 33652000
Description
Dasatynib.

Tender item

ID
ocds-pyfy63:2020-543335:obj:37
Classification
CPV / 33652000
Description
Brentuksymab.

Tender item

ID
ocds-pyfy63:2020-543335:obj:38
Classification
CPV / 33652000
Description
Aflibercept.

Tender item

ID
ocds-pyfy63:2020-543335:obj:39
Classification
CPV / 33652000
Description
Pomalidomid.

Tender item

ID
ocds-pyfy63:2020-543335:obj:40
Classification
CPV / 33652000
Description
Nintedanib.

Tender item

ID
ocds-pyfy63:2020-543335:obj:41
Classification
CPV / 33652000
Description
Fluvestrant.

Tender item

ID
ocds-pyfy63:2020-543335:obj:42
Classification
CPV / 33652000
Description
Atezolizumab.

Tender item

ID
ocds-pyfy63:2020-543335:obj:43
Classification
CPV / 33652000
Description
Niwolumab.

Tender item

ID
ocds-pyfy63:2020-543335:obj:44
Classification
CPV / 33652000
Description
Kryzotynib.

Tender item

ID
ocds-pyfy63:2020-543335:obj:45
Classification
CPV / 33652000
Description
Pembrolizumab.

Tender item

ID
ocds-pyfy63:2020-543335:obj:46
Classification
CPV / 33652000
Description
Wenetoklaks.

Tender item

ID
ocds-pyfy63:2020-543335:obj:47
Classification
CPV / 33652000
Description
Alektynib.

Tender item

ID
ocds-pyfy63:2020-543335:obj:48
Classification
CPV / 33652000
Description
Transtuzumab ematyzyna.

Tender item

ID
ocds-pyfy63:2020-543335:obj:49
Classification
CPV / 33652000
Description
Karfilzomib.

Tender item

ID
ocds-pyfy63:2020-543335:obj:50
Classification
CPV / 33652000
Description
Blinatumomab.

Tender item

ID
ocds-pyfy63:2020-543335:obj:51
Classification
CPV / 33652000
Description
Daratumumab.

Tender item

ID
ocds-pyfy63:2020-543335:obj:52
Classification
CPV / 33652000
Description
Temozolomidum.

Tender item

ID
ocds-pyfy63:2020-543335:obj:53
Classification
CPV / 33652000
Description
Rybocyklib.

Tender item

ID
ocds-pyfy63:2020-543335:obj:54
Classification
CPV / 33652000
Description
Abemacyklib.

Tender item

ID
ocds-pyfy63:2020-543335:obj:55
Classification
CPV / 33652000
Description
Pegasparagasum.

Tender item

ID
ocds-pyfy63:2020-543335:obj:56
Classification
CPV / 33652000
Description
Chlorambucilum.

Tender item

ID
ocds-pyfy63:2020-543335:obj:57
Classification
CPV / 33652000
Description
Peginterferon alfa 2a.

Tender item

ID
ocds-pyfy63:2020-543335:obj:58
Classification
CPV / 33652000
Description
Triflurydyna + Typiracy.

Tender item

ID
ocds-pyfy63:2020-543335:obj:59
Classification
CPV / 33652000
Description
Kladrybina.

Tender item

ID
ocds-pyfy63:2020-543335:obj:60
Classification
CPV / 33652000
Description
Okrelizumab.

Tender item

ID
ocds-pyfy63:2020-543335:obj:61
Classification
CPV / 33652000
Description
Natalizumab.

Tender item

ID
ocds-pyfy63:2020-543335:obj:62
Classification
CPV / 33652000
Description
Fingolimod.

Tender item

ID
ocds-pyfy63:2020-543335:obj:63
Classification
CPV / 33652000
Description
Alemtuzumabum.

Tender item

ID
ocds-pyfy63:2020-543335:obj:64
Classification
CPV / 33652000
Description
Interferon β-1a.

Tender item

ID
ocds-pyfy63:2020-543335:obj:65
Classification
CPV / 33652000
Description
Fumaran dimetylu.

Tender item

ID
ocds-pyfy63:2020-543335:obj:66
Classification
CPV / 33652000
Description
Immunoglobuliny.

Tender item

ID
ocds-pyfy63:2020-543335:obj:67
Classification
CPV / 33652000
Description
Cetuximab.

Tender item

ID
ocds-pyfy63:2020-543335:obj:68
Classification
CPV / 33652000
Description
Dexamethasoni phosphas.

Tender item

ID
ocds-pyfy63:2020-543335:obj:69
Classification
CPV / 33652000
Description
Netupitantum + Palonosetroni hydrochloridum.

Tender item

ID
ocds-pyfy63:2020-543335:obj:70
Classification
CPV / 33652000
Description
Anagrelid.

Tender item

ID
ocds-pyfy63:2020-543335:obj:71
Classification
CPV / 33652000
Description
Ponatynib.

Tender item

ID
ocds-pyfy63:2020-543335:obj:72
Classification
CPV / 33652000
Description
Romiplostym.

Tender item

ID
ocds-pyfy63:2020-543335:obj:73
Classification
CPV / 33652000
Description
Cladribinum.

Tender item

ID
ocds-pyfy63:2020-543335:obj:74
Classification
CPV / 33652000
Description
Cyclophosphamidum.

Tender item

ID
ocds-pyfy63:2020-543335:obj:75
Classification
CPV / 33652000
Description
Cyclophosphamidum.

Tender item

ID
ocds-pyfy63:2020-543335:obj:76
Classification
CPV / 33652000
Description
Fludarabina Oral.

Tender item

ID
ocds-pyfy63:2020-543335:obj:77
Classification
CPV / 33652000
Description
Hydroxycarbamidum.

Tender item

ID
ocds-pyfy63:2020-543335:obj:78
Classification
CPV / 33652000
Description
Idarubicin.

Tender item

ID
ocds-pyfy63:2020-543335:obj:79
Classification
CPV / 33652000
Description
Ifosfamid.

Tender item

ID
ocds-pyfy63:2020-543335:obj:80
Classification
CPV / 33652000
Description
Mercaptopurinum.

Tender item

ID
ocds-pyfy63:2020-543335:obj:81
Classification
CPV / 33652000
Description
Mesna.

Tender item

ID
ocds-pyfy63:2020-543335:obj:82
Classification
CPV / 33652000
Description
Tioguanine.

Tender item

ID
ocds-pyfy63:2020-543335:obj:83
Classification
CPV / 33652000
Description
Topotecan.

Tender item

ID
ocds-pyfy63:2020-543335:obj:84
Classification
CPV / 33652000
Description
Carboplatin.

Tender item

ID
ocds-pyfy63:2020-543335:obj:85
Classification
CPV / 33652000
Description
Cisplatinum.

Tender item

ID
ocds-pyfy63:2020-543335:obj:86
Classification
CPV / 33652000
Description
Cytarabina.

Tender item

ID
ocds-pyfy63:2020-543335:obj:87
Classification
CPV / 33652000
Description
Docetaxel.

Tender item

ID
ocds-pyfy63:2020-543335:obj:88
Classification
CPV / 33652000
Description
Doxorubicinum.

Tender item

ID
ocds-pyfy63:2020-543335:obj:89
Classification
CPV / 33652000
Description
Epirubicin.

Tender item

ID
ocds-pyfy63:2020-543335:obj:90
Classification
CPV / 33652000
Description
Etoposidum.

Tender item

ID
ocds-pyfy63:2020-543335:obj:91
Classification
CPV / 33652000
Description
Fluorouracilum.

Tender item

ID
ocds-pyfy63:2020-543335:obj:92
Classification
CPV / 33652000
Description
Gemcitabina.

Tender item

ID
ocds-pyfy63:2020-543335:obj:93
Classification
CPV / 33652000
Description
Methotrexatum.

Tender item

ID
ocds-pyfy63:2020-543335:obj:94
Classification
CPV / 33652000
Description
Methotrexatum.

Tender item

ID
ocds-pyfy63:2020-543335:obj:95
Classification
CPV / 33652000
Description
Mitoxantron.

Tender item

ID
ocds-pyfy63:2020-543335:obj:96
Classification
CPV / 33652000
Description
Paclitaxel.

Tender item

ID
ocds-pyfy63:2020-543335:obj:97
Classification
CPV / 33652000
Description
Pemetrexed.

Tender item

ID
ocds-pyfy63:2020-543335:obj:98
Classification
CPV / 33652000
Description
Vinorelbin.

Tender item

ID
ocds-pyfy63:2020-543335:obj:99
Classification
CPV / 33652000
Description
Capecytabina.

Tender item

ID
ocds-pyfy63:2020-543335:obj:100
Classification
CPV / 33652000
Description
Bleomycinum.

Tender item

ID
ocds-pyfy63:2020-543335:obj:101
Classification
CPV / 33652000
Description
Dacarbazinum.

Tender item

ID
ocds-pyfy63:2020-543335:obj:102
Classification
CPV / 33652000
Description
Topotecan.

Tender item

ID
ocds-pyfy63:2020-543335:obj:103
Classification
CPV / 33652000
Description
Lipegfilgrastym.

Tender item

ID
ocds-pyfy63:2020-543335:obj:104
Classification
CPV / 33652000
Description
Bicalutamid.

Tender item

ID
ocds-pyfy63:2020-543335:obj:105
Classification
CPV / 33652000
Description
Doxorubicinum liposomanum nonpegylatum.

Tender item

ID
ocds-pyfy63:2020-543335:obj:106
Classification
CPV / 33652000
Description
Vincristinum.

Tender item

ID
ocds-pyfy63:2020-543335:obj:107
Classification
CPV / 33652000
Description
Denozumab.

Tender item

ID
ocds-pyfy63:2020-543335:obj:108
Classification
CPV / 33652000
Description
Panitumumab.

Tender item

ID
ocds-pyfy63:2020-543335:obj:109
Classification
CPV / 33652000
Description
Trastuzumab.

Tender item

ID
ocds-pyfy63:2020-543335:obj:110
Classification
CPV / 33652000
Description
Bortezomib.

Tender item

ID
ocds-pyfy63:2020-543335:obj:111
Classification
CPV / 33652000
Description
Lenalidomid.

Tender item

ID
ocds-pyfy63:2020-543335:obj:112
Classification
CPV / 33652000
Description
Paklitaksel w postaci nanocząsteczkowego kompleksu z albuminą.

Tender item

ID
ocds-pyfy63:2020-543335:obj:113
Classification
CPV / 33652000
Description
Palbocyklib.

Tender item

ID
ocds-pyfy63:2020-543335:obj:114
Classification
CPV / 33652000
Description
Temozolomidum.

Tender item

ID
ocds-pyfy63:2020-543335:obj:115
Classification
CPV / 33652000
Description
Melphalanum.

Parties

Roles
buyer
Organization name
Szpital Specjalistyczny im. Jędrzeja Śniadeckiego w Nowym Sączu
Street address
ul. Młyńska 10
Locality
Nowy Sącz
Postal code
33-300
Country
PL
Contact name
zespół ds. zamówień publicznych
E-mail
zamowieniapubliczne@szpitalnowysacz.pl
Phone
+48 184436635
Fax
+48 184436635
Website
www.szpitalnowysacz.pl

Organization data Organization in JSON